Skip to main content
. 2021 Jan 9;50(3):841–851. doi: 10.1093/ije/dyaa271

Table 1.

Life expectancy (LE), disability-free life expectancy and life expectancy with disability at age 65 years from the Cognitive Function and Ageing Studies (CFAS I and CFAS II) and the difference between the two studies

CFAS I CFAS II Difference
(CFAS II – CFAS I)
Men Estimate (95% CI) Estimate (95% CI) Estimate (95% CI)
Life expectancy (years) 13.2 (12.6–13.8) 17.8 (17.1–18.4) 4.6 (3.7–5.5)
Disability-free LE (years) 9.9 (9.2–10.6) 13.7 (12.9–14.4) 3.7 (2.7–4.8)
Disability-free LE (% of LE) 75.2 (73.5–76.9) 76.8 (75.3–78.4) 1.6 (-0.6–3.9)
LE with disability (years) 3.3 (2.9–3.6) 4.1 (3.7–4.5) 0.8 (0.3–1.4)
LE with disability (% of LE) 24.8 (23.1–26.5) 23.2 (21.6–24.7) −1.6 (-3.9–0.6)
Women Estimate (95% CI) Estimate (95% CI) Estimate (95% CI)
Life expectancy (years) 17.6 (17.0–18.2) 19.6 (18.9–20.3) 2.1 (1.1–3.0)
Disability-free LE (years) 9.8 (9.2–10.4) 11.7 (11.0–12.5) 2.0 (1.0–2.9)
Disability-free LE (% of LE) 55.6 (54.0–57.2) 59.7 (58.0–61.4) 4.1 (1.8–6.5)
LE with disability (years) 7.8 (7.3–8.3) 7.9 (7.3–8.5) 0.1 (-0.7–0.9)
LE with disability (% of LE) 44.4 (42.8–46.0) 40.3 (38.6–42.0) −4.1 (-6.5 – -1.8)

Models stratified by sex and study. For CFAS I, men total N = 2615, CFAS II men N = 2866, CFAS I women N = 3693 and CFAS II women N = 3231.